Entitlement Options Offer
Filed with ASX ·
6ix hasn’t read this filing yet.
Neurizon Therapeutics Limited on 6ix
Earlier from Neurizon Therapeutics
- Epichem Completes Final Loan Repayment
- Epichem Completes Build of OHD Benchtop Flow Reactor
- Monepantel and monepantel sulfone COVID-19 anti-viral update
- PharmAust and WEHI to Investigate HTLV-1 Viral Infections
- Phase IIb Dog Trial Achieves Interim Clinical Endpoints
Later from Neurizon Therapeutics
- Prospectus
- Following Extension of Survival, PAA Prepares Phase 3 Trial
- MPL Manufacturing and Human Trials Update
- Canine phase 2b cancer trial expands to New Zealand
- MND & COVID-19 Phase 1 Clinical Trials On-Track
Follow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics